OraSure Technologies, Inc. OSUR

OSUR Company Overview

OraSure Technologies, Inc. is a U.S.-based diagnostics and life sciences company that develops and commercializes rapid diagnostic tests, sample collection devices, and molecular collection technologies used in infectious disease detection, microbiome research, and genomic applications. The company operates primarily in the healthcare diagnostics and biotechnology tools industries, serving clinical laboratories, public health agencies, research institutions, hospitals, employers, and government organizations. OraSure is best known for its oral fluid-based testing technologies, including products used for HIV and hepatitis C screening, as well as DNA and RNA sample collection systems utilized in molecular diagnostics and research workflows.

The company’s principal revenue drivers include diagnostic testing products and molecular collection systems marketed through its Diagnostics and Molecular Solutions businesses. OraSure has historically differentiated itself through proprietary oral fluid collection technology, non-invasive specimen collection methods, and regulatory expertise in FDA-authorized rapid testing products. Founded in the late 1980s through predecessor entities and later expanded through acquisitions and product diversification, the company evolved from a niche diagnostics manufacturer into a broader provider of specimen collection and molecular testing technologies. Public filings and industry reporting indicate that the company expanded materially through acquisitions such as DNA Genotek, which strengthened its genomics and microbiome portfolio.